Tetrabromobisphenol A (TBBPA): Possible modes of action of toxicity and carcinogenicity in rodents

Food and Chemical Toxicology

Volumn 80, Issue , 2015, Pages 206-214

  Lai, David Y ^a   Kacew, Sam ^b   Dekant, Wolfgang ^c  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Carcinogenicity; Mode of action; Potential risk; TBBPA; Toxicity

Indexed keywords

ESTROGEN; LIOTHYRONINE; TETRABROMOBISPHENOL A; THYROTROPIN; THYROXINE; FLAME RETARDANT; POLYBROMINATED BIPHENYL;

CARCINOGENICITY; CELL PROLIFERATION; COMPETITIVE INHIBITION; DEVELOPMENTAL TOXICITY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; GENE MUTATION; GENOTOXICITY; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MIXED MULLERIAN TUMOR; NONHUMAN; REVIEW; THYROID HYPERPLASIA; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TUMOR SUPPRESSOR GENE; UTERUS TUMOR; ANIMAL; CARCINOGEN TESTING; PROCEDURES;

MAMMALIA; RATTUS; RODENTIA;

ANIMALS; CARCINOGENICITY TESTS; FLAME RETARDANTS; HUMANS; POLYBROMINATED BIPHENYLS;

EID: 84926191307     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2015.03.023     Document Type: Review

References (69)

1. Akanni A., Abul-Hajj Y.J. Estrogen-nucleic acid adducts: dissection of the reaction of 3, 4-estrone quinone and its radical anion and radical cation with deoxynucleosides and DNA. Chem. Res. Toxicol 1999, 12:1247-1253.
2. Alison R.H., Capen C.C., Prentice D.E. Neoplastic lesions of questionable significance to humans. Toxicol. Pathol 1994, 22:179-186.
3. Beetstra J.B., van Engelen J.G., Karels P., van der Hoek H.J., de Jong M., Docter R., et al. Thyroxine and 3,3',5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases. Endocrinology 1991, 128:741-746. 10.1210/endo-128-2-741.
4. Behnisch P.A., Hosoe K., Sakai S. Brominated dioxin-like compounds: in vitro assessment in comparison to classical dioxin-like compounds and other polyaromatic compounds. Environ. Int 2003, 29:861-877.
5. Blagosklonny M.V. p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect. FASEB J. 2000, 14:1901-1907. 10.1096/fj.99-1078rev.
6. Boobis A.R., Cohen S.M., Dellarco V., McGregor D., Meek M.E., Vickers C., et al. IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol 2006, 36:781-792. 10.1080/10408440600977677.
7. Canada Risk management scope for Phenol, 4,4'-(1-methylethylidene) bis[2,6-dibromo-(Tetrabromobisphenol A) 2012, Government of Canada, Environment Canada, Health Canada.
8. Canada Screening assessment report of Phenol, 4,4'-(1-methylethylidene) bis[2,6-dibromo- (Tetrabromobisphenol A, TBBPA; CAS 79-94-7), Ethanol, 2,2'-[(1-methylethylidene)bis[(2,6-dibromo-4,1-phenylene)oxy]]bis (known as TBBPA bis(2-hydroxyethyl ether, CAS 4162-45-2) and Benzene, 1,1'-(1-methylethylidene)bis[3,5-dibromo-4-(2-propenyloxy)-(TBBPA bis(allylether, CAS 25327-89-3) 2013, Government of Canada, Environment Canada, Health Canada.
9. Choksi N.Y., Jahnke G.D., St Hilaire C., Shelby M. Role of thyroid hormones in human and laboratory animal reproductive health. Birth Defects Res. B Dev. Reprod. Toxicol 2003, 68:479-491. 10.1002/bdrb.10045.
10. Colnot T., Kacew S., Dekant W. Mammalian toxicology and human exposures to the flame retardant 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol (TBBPA): implications for risk assessment. Arch. Toxicol 2014, 88:553-573. 10.1007/s00204-013-1180-8.
11. Conova S. Estrogen's role in cancer. In Vivo 2003, 2:10. Columbia Univ Health Sci.
12. Cope R.B., Kacew S., Dourson M. A reproductive, developmental and neurobehavioral study following oral exposure of tetrabromobisphenol A on Sprague-Dawley rats. Toxicology 2015, 329:49-59. 10.1016/j.tox.2014.12.013.
13. CPCD The Carcinogenic Potency Project at the University of California, Berkeley and the Lawrence Berkeley National Laboratory (1980-2011) 2011.
14. Di Liegro I. Thyroid hormones and the central nervous system of mammals (Review). Mol. Med. Rep 2008, 1:279-295.
15. ECB European Union Risk Assessment Report - 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol (tetrabromobisphenol-A or TBBP-A) (CAS: 79-94-7) Part II - human health 2006, Institute for Health and Consumer Protection, European Chemicals Bureau, European Commission Joint Research Centre, 4th Priority List, Luxembourg: Office for Official Publications of the European Communities.
16. ECB European Union Risk Assessment Report - 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol (tetrabromobisphenol-A or TBBP-A) (CAS: 79-94-7) Part I - environment (final draft) 2008.
17. EFSA EFSA panel on contaminants in the food chain (CONTAM): scientific opinion on Tetrabromobisphenol A (TBBPA) and its derivatives in food EFSA panel on contaminants in the food chain. EFSA J. 2011, 9:2477.
18. Forhead A.J., Fowden A.L. Thyroid hormones in fetal growth and prepartum maturation. J. Endocrinol 2014, 221:R87-R103. 10.1530/JOE-14-0025.
19. Fukuda N., Ito Y., Yamaguchi M., Mitumori K., Koizumi M., Hasegawa R., et al. Unexpected nephrotoxicity induced by tetrabromobisphenol A in newborn rats. Toxicol. Lett 2004, 150:145-155.
20. Germer S., Piersma A.H., van der Ven L., Kamyschnikow A., Fery Y., Schmitz H.J., et al. Subacute effects of the brominated flame retardants hexabromocyclododecane and tetrabromobisphenol A on hepatic cytochrome P450 levels in rats. Toxicology 2006, 218:229-236. 10.1016/j.tox.2005.10.019.
21. Goodman D.G., Boorman G.A., Strandberg J.D. Selection and use of the B6C3F1 mouse and F344 rat in long-term bioassays for carcinogenicity. Handbook of Carcinogenic Testing 1994, 347-390. Noyes Publications, Park Ridge, NJ. 2nd ed. H.A. Milman, E.K. Weisburger (Eds.).
22. Gosavi R.A., Knudsen G.A., Birnbaum L.S., Pedersen L.C. Mimicking of estradiol binding by flame retardants and their metabolites: a crystallographic analysis. Environ. Health Perspect 2013, 121:1194-1199. 10.1289/ehp.1306902.
23. Hagmar L., Sjödin A., Höglund P., Thuresson K., Rylander L., Bergman A. Biological half-lives of polybrominated diphenyl ethers and tetrabromobisphenol A in exposed workers. Organohalogen Comp 2000, 47:198-201.
24. Hakk H., Larsen G., Bergman A., Orn U. Metabolism, excretion and distribution of the flame retardant tetrabromobisphenol-A in conventional and bile-duct cannulated rats. Xenobiotica 2000, 30:881-890. 10.1080/004982500433309.
25. Hamers T., Kamstra J.H., Sonneveld E., Murk A.J., Zegers B.N., Boon J.P., et al. In vitro screening of the endocrine disrupting potency of brominated flame retardants and their metabolites 2004, Abstract from the Third International Workshop on Brominated Flame Retardants, June 6-9, 2004, Toronto, Canada.
26. Hamers T., Kamstra J.H., Sonneveld E., Murk A.J., Kester M.H., Andersson P.L., et al. In vitro profiling of the endocrine-disrupting potency of brominated flame retardants. Toxicol. Sci 2006, 92:157-173.
27. Hood A., Klaassen C.D. Differential effects of microsomal enzyme inducers on in vitro thyroxine (T(4)) and triiodothyronine (T(3)) glucuronidation. Toxicol. Sci 2000, 55:78-84.
28. Hood A., Hashmi R., Klaassen C.D. Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy. Toxicol. Appl. Pharmacol 1999, 160:163-170. 10.1006/taap.1999.8752.
29. IARC Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis 1997, vol. 147:1-5. World Health Organization, Geneva, IARC Scientific Publications No.
30. IPCS International Programme on Chemical Safety workshop on developing a conceptual framework for cancer risk assessment, February 16-18, 1999, Lyon, France 1999, IPCS/99.6. World Health Organization, Geneva.
31. Kacew S., Festing M.F. Role of rat strain in the differential sensitivity to pharmaceutical agents and naturally occurring substances. J. Toxicol. Environ. Health 1996, 47:1-30. 10.1080/009841096161960-2840.
32. Kacew S., Ruben Z., McConnell R.F. Strain as a determinant factor in the differential responsiveness of rats to chemicals. Toxicol. Pathol 1995, 23:701-714. discussion 714-705.
33. Kitamura S., Suzuki T., Sanoh S., Kohta R., Jinno N., Sugihara K., et al. Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds. Toxicol. Sci 2005, 84:249-259.
34. Knudsen G.A., Sanders J.M., Sadik A.M., Birnbaum L.S. Disposition and kinetics of tetrabromobisphenol A in female Wistar Han rats. Toxicol. Rep 2014, 1:214-223. 10.1016/j.toxrep.2014.03.005.
35. Koibuchi N. The role of thyroid hormone on functional organization in the cerebellum. Cerebellum 2013, 12:304-306. 10.1007/s12311-012-0437-8.
36. Kuester R.K., Solyom A.M., Rodriguez V.P., Sipes I.G. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats. Toxicol. Sci 2007, 96:237-245. 10.1093/toxsci/kfm006.
37. Larsen P.R., Zavacki A.M. The role of the iodothyronine deiodinases in the physiology and pathophysiology of thyroid hormone action. Eur. Thyroid J. 2012, 1:232-242. 10.1159/000343922.
38. Lax S.F. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 2004, 444:213-223. 10.1007/s00428-003-0947-3.
39. Mariussen E., Fonnum F. The effect of brominated flame retardants on neurotransmitter uptake into rat brain synaptosomes and vesicles. Neurochem. Int 2003, 43:533-542.
40. Marsili A., Zavacki A.M., Harney J.W., Larsen P.R. Physiological role and regulation of iodothyronine deiodinases: a 2011 update. J. Endocrinol. Invest 2011, 34:395-407. 10.3275/7615.
41. Meek M.E., Bucher J.R., Cohen S.M., Dellarco V., Hill R.N., Lehman-McKeeman L.D., et al. A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol 2003, 33:591-653. 10.1080/713608373.
42. Meek M.E., Boobis A., Cote I., Dellarco V., Fotakis G., Munn S., et al. New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis. J. Appl. Toxicol 2014, 34:1-18. 10.1002/jat.2949.
43. Molina-Molina J.M., Amaya E., Grimaldi M., Saenz J.M., Real M., Fernandez M.F., et al. In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors. Toxicol. Appl. Pharmacol 2013, 272:127-136. 10.1016/j.taap.2013.05.015.
44. Muller P.A., Vousden K.H. p53 mutations in cancer. Nat. Cell Biol 2013, 15:2-8. 10.1038/ncb2641.
45. Negro R., Soldin O.P., Obregon M.J., Stagnaro-Green A. Hypothyroxinemia and pregnancy. Endocr. Pract 2011, 17:422-429. 10.4158/EP10309.RA.
46. Neumann F. Early indicators for carcinogenesis in sex-hormone-sensitive organs. Mutat. Res 1991, 248:341-356.
47. NTP Technical Report on the toxicology studies of tetrabromobisphenol A (CAS NO. 79-94-7) in F344/NTac rats and B6C3F1/N mice and toxicology and carcinogenesis study of tetrabromobisphenol A in Wistar Han [Crl:WI(Han)] rats and B6C3F1/N mice (gavage studies) 2014, NTP TR 587. National Toxicology Program, Research Triangle Park, NC.
48. Ohta R., Takagi A., Ohmukai H., Marumo H., Ono A., Matsushima Y., et al. Ovariectomized mouse uterotrophic assay of 36 chemicals. J. Toxicol. Sci 2012, 37:879-889.
49. Olsen C.M., Meussen-Elholm E.T., Samuelsen M., Holme J.A., Hongslo J.K. Effects of the environmental oestrogens bisphenol A, tetrachlorobisphenol A, tetrabromobisphenol A, 4-hydroxybiphenyl and 4,4'-dihydroxybiphenyl on oestrogen receptor binding, cell proliferation and regulation of oestrogen sensitive proteins in the human breast cancer cell line MCF-7. Pharmacol. Toxicol 2003, 92:180-188.
50. Osimitz T.G., Dourson M.L., Hayes A.W., Kacew S. Crystallographic analysis and mimicking of estradiol binding: interpretation and speculation. Environ. Health Perspect 2014, 122:A91. 10.1289/ehp.1307987.
51. Osimitz T.G., Droege W., Hayes A.W. Subchronic toxicology of Tetrabromobisphenol A (TBBPA) in CD® Rats 2014, The Toxicologist, PS 1087i, 285.
52. Parkinson A., Ogilvie B.W., Buckley D.B., Kazmi F., Czerwinski M., Parkinson O. Biotransformation of xenobiotics. Casarett & Doull's Toxicology. The Basic Science of Poisons 2013, 185-366. McGraw Hill Education, New York. C.D. Klaassen (Ed.).
53. Raftogianis R., Creveling C., Weinshilboum R., Weisz J. Estrogen metabolism by conjugation. J. Natl. Cancer Inst. Monogr 2000, 27:113-124.
54. Richardson T.A., Klaassen C.D. Role of UDP-glucuronosyltransferase (UGT) 2B2 in metabolism of triiodothyronine: effect of microsomal enzyme inducers in Sprague Dawley and UGT2B2-deficient Fischer 344 rats. Toxicol. Sci 2010, 116:413-421. 10.1093/toxsci/kfq125.
55. Riu A., le Maire A., Grimaldi M., Audebert M., Hillenweck A., Bourguet W., et al. Characterization of novel ligands of ERα, Erβ, and PPARγ: the case of halogenated bisphenol A and their conjugated metabolites. Toxicol. Sci 2011, 122:372-382. 10.1093/toxsci/kfr132.
56. Samuelsen M., Olsen C., Holme J.A., Meussen-Elholm E., Bergmann A., Hongslo J.K. Estrogen-like properties of brominated analogs of bisphenol A in the MCF-7 human breast cancer cell line. Cell Biol. Toxicol 2001, 17:139-151.
57. Schauer U.M., Volkel W., Dekant W. Toxicokinetics of tetrabromobisphenol A in humans and rats after oral administration. Toxicol. Sci 2006, 91:49-58. 10.1093/toxsci/kfj132.
58. Sjodin A., Patterson D.G., Bergman A. A review on human exposure to brominated flame retardants - particularly polybrominated diphenyl ethers. Environ. Int 2003, 29:829-839. 10.1016/S0160-4120(03)00108-9.
59. Tada Y., Fujitani T., Yano N., Takahashi H., Yuzawa K., Ando H., et al. Effects of tetrabromobisphenol A, brominated flame retardant, in ICR mice after prenatal and postnatal exposure. Food Chem. Toxicol 2006, 44:1408-1413. 10.1016/j.fct.2006.03.006.
60. van Raaij J.A., Kaptein E., Visser T.J., van den Berg K.J. Increased glucuronidation of thyroid hormone in hexachlorobenzene-treated rats. Biochem. Pharmacol 1993, 45:627-631.
61. Van der Ven L.T., Van de Kuil T., Verhoef A., Verwer C.M., Lilienthal H., Leonards P.E., et al. Endocrine effects of tetrabromobisphenol-A (TBBPA) in Wistar rats as tested in a one-generation reproduction study and a subacute toxicity study. Toxicology 2008, 245:76-89. 10.1016/j.tox.2007.12.009.
62. Visser T.J., Kaptein E., Harpur E.S. Differential expression and ciprofibrate induction of hepatic UDP-glucuronyltransferases for thyroxine and triiodothyronine in Fischer rats. Biochem. Pharmacol 1991, 42:444-446.
63. Visser T.J., Kaptein E., van Toor H., van Raaij J.A., van den Berg K.J., Joe C.T., et al. Glucuronidation of thyroid hormone in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions. Endocrinology 1993, 133:2177-2186. 10.1210/endo.133.5.8404669.
64. Vranckx R., Rouaze-Romet M., Savu L., Mechighel P., Maya M., Nunez E.A. Regulation of rat thyroxine-binding globulin and transthyretin: studies in thyroidectomized and hypophysectomized rats given tri-iodothyronine or/and growth hormone. J. Endocrinol 1994, 142:77-84.
65. Wetzel L.T., Luempert L.G., Breckenridge C.B., Tisdel M.O., Stevens J.T., Thakur A.K., et al. Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague-Dawley and Fischer 344 rats. J. Toxicol. Environ. Health 1994, 43:169-182. 10.1080/15287399409531913.
66. Williams A.L., DeSesso J.M. The potential of selected brominated flame retardants to affect neurological development. J. Toxicol. Environ. Health B Crit. Rev 2010, 13:411-448. 10.1080/10937401003751630.
67. Yoshida M., Katsuda S., Tanimoto T., Asai S., Nakae D., Kurokawa Y., et al. Induction of different types of uterine adenocarcinomas in Donryu rats due to neonatal exposure to high-dose p-t-octylphenol for different periods. Carcinogenesis 2002, 23:1745-1750.
68. Yoshida M., Katashima S., Ando J., Tanaka T., Uematsu F., Nakae D., et al. Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initiated with N-ethyl-N'-nitro-N-nitrosoguanidine, with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism. Carcinogenesis 2004, 25:2257-2264. 10.1093/carcin/bgh225.
69. Yoshida M., Katsuda S., Maekawa A. Involvements of estrogen receptor, proliferating cell nuclear antigen and p53 in endometrial adenocarcinoma development in Donryu rats. J. Toxicol. Pathol 2012, 25:241-247. 10.1293/tox.25.241.